首页 > 市场调查报告书 > 医疗设备

体外诊断生技设备

市场调查报告书

商品编码

1746960

日本新生儿筛检市场报告（按产品、技术、检测类型和地区）2025-2033

Japan Newborn Screening Market Report by Product, Technology, Test Type, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年，日本新生儿筛检市场规模达6,440万美元。展望未来， IMARC Group预计到2033年，该市场规模将达到1.075亿美元，2025-2033年期间的复合年增长率（CAGR）为5.9%。医疗技术的持续创新，旨在提高疾病检测的准确性和效率，是推动区域市场发展的主要动力。

新生儿筛检包含一系列实验室评估和即时检查，旨在及早发现、诊断和干预出生后可能不会立即显现的遗传、代谢、血液或荷尔蒙失调。其主要目的是及早发现可能导致严重发病率、死亡率和智力障碍 (ID) 的疾病，以便在症状显现之前及时启动治疗。典型的新生儿筛检流程包括从婴儿足跟采集少量血样，进行简单的血液检测。随后，对血液样本进行检测以评估各种状况，包括代谢紊乱、内分泌失调以及血液相关疾病，例如苯丙酮尿症 (PKU)、囊性纤维化和镰状细胞性贫血。如果初步筛检结果显示新生儿患有遗传性疾病，则需要进行额外的确认性检测以确认诊断。这可以及时实施适当的治疗，并制定后续护理计划，以保障婴儿的健康。

日本新生儿筛检市场趋势：

日本新生儿筛检市场正在经历显着成长，这主要得益于父母（尤其是新手父母）对子女健康的日益关注。这种担忧源于婴儿先天性疾病的日益增多。父母越来越意识到早期发现和诊断在促进及时医疗干预和治疗方面的关键作用，这进一步推动了市场的扩张。医疗技术和基因检测的进步显着拓宽了可筛检疾病的范围，增强了市场前景。各国政府和医疗保健机构越来越多地采用新生儿筛检项目，这进一步促进了市场的积极发展。持续的产品创新，例如新一代定序和串联质谱技术的集成，提高了筛检的准确性和速度，进一步促进了市场的成长。直接面向消费者的基因检测的普及以及对个人化医疗的日益关注，正在推动根据个人特定基因特征制定个人化治疗方案，从而进一步刺激市场需求。医疗保健支出增加、数位化快速发展、互联网速度加快、线上健康社区的出现以及广泛的研发 (R&D) 工作等因素将有助于预测期内市场的整体成长和进步。

日本新生儿筛检市场细分：

产品洞察：

仪器
试剂

技术洞察：

串联质谱法
脉搏血氧仪
基于酵素的测定
DNA检测
电泳
其他的

测试类型洞察：

干血斑测试
慢性肾臟病
听力筛检

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本新生儿筛检市场目前表现如何？未来几年将如何表现？
COVID-19 对日本新生儿筛检市场有何影响？
日本新生儿筛检市场依产品划分是怎样的？
日本新生儿筛检市场依技术分類的分布如何？
根据测试类型，日本新生儿筛检市场是如何分類的？
日本新生儿筛检市场的价值链分为哪些阶段？
日本新生儿筛检的主要驱动因素和挑战是什么？
日本新生儿筛检市场的结构是怎么样的？主要参与者是谁？
日本新生儿筛检市场的竞争程度如何？

本报告回答的关键问题：

日本新生儿筛检市场目前表现如何？未来几年将如何表现？
COVID-19 对日本新生儿筛检市场有何影响？
日本新生儿筛检市场依产品划分是怎样的？
日本新生儿筛检市场依技术分類的分布如何？
根据测试类型，日本新生儿筛检市场是如何分類的？
日本新生儿筛检市场的价值链分为哪些阶段？
日本新生儿筛检的主要驱动因素和挑战是什么？
日本新生儿筛检市场的结构是怎么样的？主要参与者是谁？
日本新生儿筛检市场的竞争程度如何？

Japan newborn screening market size reached USD 64.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 107.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.9% during 2025-2033. Continuous innovations in medical technology for more accurate outcomes and efficiency of disease detection are primarily driving the regional market.

Newborn screening encompasses a series of laboratory assessments and point-of-care examinations designed for the early detection, diagnosis, and intervention of genetic, metabolic, hematological, or hormonal disorders that may not manifest immediately after birth. The primary objective is to identify diseases that have the potential to cause significant morbidity, mortality, and intellectual disability (ID) at an early stage, enabling prompt initiation of treatment before symptoms become evident. The typical newborn screening process involves the collection of a small blood sample from the baby's heel, which is subjected to a straightforward blood test. Subsequently, the blood sample undergoes testing to assess various conditions, including metabolic disorders, endocrine irregularities, and blood-related ailments such as phenylketonuria (PKU), cystic fibrosis, and sickle cell anemia. Should the initial screening results suggest a genetic disorder in the newborn, additional confirmatory testing becomes necessary to validate the diagnosis. This enables timely administration of appropriate treatment and the establishment of a follow-up care plan for the infant's well-being.

Japan Newborn Screening Market Trends:

The Japan newborn screening market is witnessing significant growth, primarily driven by heightened parental concerns for their children's health, especially among new parents. This concern is rooted in the increasing prevalence of congenital conditions in infants. Parents are becoming more aware of the critical role early detection and diagnosis play in facilitating timely medical intervention and treatment, further propelling the market's expansion. Advancements in medical technology and genetic testing have significantly broadened the range of disorders that can be screened for, enhancing the market's prospects. Governments and healthcare organizations are increasingly adopting newborn screening programs, adding to the market's positive trajectory. Ongoing product innovations, such as the integration of next-generation sequencing and tandem mass spectrometry, offer improved screening accuracy and speed, further bolstering market growth. The availability of direct-to-consumer genetic testing and a growing focus on personalized medicine are driving tailored treatments tailored to individuals' specific genetic profiles, further stimulating market demand. Factors such as increased healthcare expenditure, rapid digitization, higher internet speeds, the emergence of online health communities, and extensive research and development (R&D) efforts will contribute to the market's overall growth and advancement over the forecasted period.

Japan Newborn Screening Market Segmentation:

Product Insights:

Instruments
Reagents

Technology Insights:

Tandem Mass Spectrometry
Pulse Oximetry
Enzyme Based Assay
DNA Assay
Electrophoresis
Others

Test Type Insights:

Dry Blood Spot Test
CCHD
Hearing Screen

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan newborn screening market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan newborn screening market?
What is the breakup of the Japan newborn screening market on the basis of product?
What is the breakup of the Japan newborn screening market on the basis of technology?
What is the breakup of the Japan newborn screening market on the basis of test type?
What are the various stages in the value chain of the Japan newborn screening market?
What are the key driving factors and challenges in the Japan newborn screening?
What is the structure of the Japan newborn screening market and who are the key players?
What is the degree of competition in the Japan newborn screening market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Newborn Screening Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Newborn Screening Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Newborn Screening Market - Breakup by Product

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Newborn Screening Market - Breakup by Technology

7.1 Tandem Mass Spectrometry
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Pulse Oximetry
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Enzyme Based Assay
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 DNA Assay
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Electrophoresis
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
7.6 Others
- 7.6.1 Historical and Current Market Trends (2019-2024)
- 7.6.2 Market Forecast (2025-2033)

8 Japan Newborn Screening Market - Breakup by Test Type

8.1 Dry Blood Spot Test
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 CCHD
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Hearing Screen
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Newborn Screening Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Newborn Screening Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis